Dabigatran Etexilate and Risk of Myocardial Infarction, Other Cardiovascular Events, Major Bleeding, and All‐Cause Mortality: A Systematic Review and Meta‐analysis of Randomized Controlled Trials

BACKGROUND: Signals of an increased risk of myocardial infarction (MI) have been identified with dabigatran etexilate in randomized controlled trials (RCTs). METHODS AND RESULES: We conducted searches of the published literature and a clinical trials registry maintained by the drug manufacturer. Cri...

Descripción completa

Detalles Bibliográficos
Autores principales: Douxfils, Jonathan, Buckinx, Fanny, Mullier, François, Minet, Valentine, Rabenda, Véronique, Reginster, Jean‐Yves, Hainaut, Philippe, Bruyère, Olivier, Dogné, Jean‐Michel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4309041/
https://www.ncbi.nlm.nih.gov/pubmed/24906369
http://dx.doi.org/10.1161/JAHA.113.000515

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4309041/
https://www.ncbi.nlm.nih.gov/pubmed/24906369
http://dx.doi.org/10.1161/JAHA.113.000515

Ejemplares similares